GlassScriptPhysician profile
Edward J Mcmanus
NPI 1871569996
$2,141.15
in general payments reported to CMS, 2019-2025
17 companies · $708 in 2025
The $708 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $74.01 · 2021: $129 · 2022: $54.04 · 2023: $635 · 2024: $291 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $642.66 | 2022-2025 | |
| Gilead Sciences, INC. | $420.90 | 2019-2025 | |
| Organogenesis INC. | $178.65 | 2023-2024 | Puraply |
| La Jolla Pharmaceutical Company | $166.31 | 2020-2021 | |
| Melinta Therapeutics, LLC | $148.27 | 2020-2023 | Rezzayo |
| Merck Sharp & Dohme LLC | $144.03 | 2019-2025 | Pifeltro |
| Aimmune Therapeutics, INC. | $125.00 | 2025 | Zenpep |
| Shionogi INC | $121.97 | 2025 | Fetroja |
| Urgo Medical North America, LLC | $39.07 | 2024-2025 | Urgok2 |
| Cashflow Solutions, LLC | $27.42 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Angiodynamics, INC. | $24.62 | 2019 | |
| Misonix INC | $23.25 | 2019 | |
| Kerecis Limited | $21.19 | 2019 | |
| Smith+Nephew, INC. | $16.67 | 2024 | Collagenase Santyl |
| Viiv Healthcare Company | $14.91 | 2023 | Cabenuva |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $14.58 | 2023 | Flexitouch Plus, Entre Plus |
| Janssen Biotech, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Mcmanus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.